Countries and Hotels

Airports and Hotels

Weather Forecast

PHARMACEUTICAL INDUSTRY NEWS

Yahoo! News: Business - Pharmaceutical
Business - Pharmaceutical

Orexigen signs $1 billion obesity drug deal (AP)
AP - Shares of Orexigen Therapeutics Inc. surged Thursday after the drugmaker said it signed a $1 billion co-development agreement for its experimental obesity drug Contrave with Takeda Pharmaceuticals.
Pharmacy measure in ND Supreme Court's hands (AP)
AP - Supporters of a voter initiative that could help bring cheaper prescription drugs to North Dakota are hoping a legal technicality won't keep them from getting the issue placed on the ballot.
Ex-hedge fund manager charged with insider trading (Reuters)
Reuters - A former hedge fund manager has been accused by a U.S. regulator of illegal insider trading in MedImmune Inc securities prior to the acquisition of the pharmaceutical company by Britain's AstraZeneca Plc.
U.S. to aggressively pursue drug misbranding cases (Reuters)
Reuters - The U.S. Department of Justice will continue to "aggressively pursue" pharmaceutical companies that illegally market drugs for uses that have not been approved by health regulators, a top agency official said on Wednesday.
Pfizer buying FoldRx for undisclosed amount (AP)
AP - Pfizer Inc. said Wednesday it will buy privately held FoldRx Pharmaceuticals Incl. for an undisclosed amount, expanding its pipeline of potential products.
Bayer and Bristol's rival clot drugs both impress (Reuters)
Reuters - Rival anti-clotting drugs from Bayer (BAYGn.DE) and Bristol-Myers Squibb both impressed in clinical trials, keeping them firmly in the race to displace the old, problematic heart drug warfarin.
Genzyme board rejects Sanofi bid (AFP)
AFP - The board of directors at US biotechnology firm Genzyme has unanimously rejected an 18.5-billion-dollar takeover offer from French pharmaceutical giant Sanofi-Aventis, Genzyme said Monday.
Sanofi-Aventis makes 18.5 bln dollar bid for US Genzyme (AFP)
AFP - French pharmaceutical group Sanofi-Aventis unveiled Sunday an 18.5 billion dollar (14.5 billion euro) offer for US biotechnology firm Genzyme, hinting it may launch a hostile bid.
Roche says no decision on job cuts this week (Reuters)
Reuters - Swiss drugmaker Roche Holding AG said on Sunday it would not make any decision on job cuts this week, after Swiss newspaper Sonntag reported it could be about to cut thousands of positions.
FDA denies accelerated approval for cancer drug (AP)
AP - Federal regulators have ruled that a potential breast cancer treatment from ImmunoGen failed to meet the standard for accelerated approval, the company said Friday.
Chindex sells $14 million in stock to Fosun Pharma (AP)
AP - Chindex International sold $14 million of its shares to another Chinese medical concern as part of its plans to form a new joint venture, the company said Friday.
Schweitzer cooking up new plan for cheap drugs (AP)
AP - Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid.
Novartis to build vaccine plant in Brazil (AFP)
AFP - The Swiss pharmaceutical group Novartis plans to build Latin America's first vaccine factory in Brazil with an investment of 300 to 500 million dollars, the financial daily Valor reported Thursday.
Novartis takes control of eye care firm Alcon (AP)
AP - Swiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion.
Canadian sentenced for selling fake cancer drug (AP)
AP - A Canadian man was sentenced Wednesday to nearly three years in federal prison for selling fake cancer drugs over the Internet.
Somaxon, Procter & Gamble co-promote insomnia drug (AP)
AP - Somaxon Pharmaceuticals Inc. will team with Procter & Gamble Co. to co-promote the insomnia treatment Silenor to thousands of doctors and pharmacies.
Roche in drug development deal with US firm (AP)
AP - Swiss pharmaceutical company Roche Group says it has teamed up with Massachusetts-based Aileron Therapeutics to develop a new class of drugs in a deal potentially worth over $1.1 billion.
Many drugs for U.S. kids tested in poor countries (Reuters)
Reuters - A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available.
FDA eyes Jazz Pharmaceuticals fibromyalgia drug (AP)
AP - Shares of Jazz Pharmaceuticals Inc. jumped Wednesday after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.
FDA staff: Jazz drug works, safeguards an issue (Reuters)
Reuters - U.S. drug reviewers said a Jazz Pharmaceuticals Inc medicine helped patients with fibromyalgia, sending shares up as much as 16 percent Wednesday on hopes an approval could sharply boost the company's sales.

WORLD NEWS

REGIONAL NEWS

BUSINESS NEWS

TECHNOLOGY NEWS

SCIENCE NEWS

USA NEWS

ENTERTAINMENT NEWS

HEALTH NEWS

Google NEWS

Countries and Hotels

Airports and Hotels

Weather Forecast